Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1964
|
| gptkbp:ATCCode |
N06AA10
|
| gptkbp:brand |
gptkb:nortriptyline
|
| gptkbp:CASNumber |
72-69-5
|
| gptkbp:chemicalFormula |
C19H21N
|
| gptkbp:contraindication |
MAOI use
recent myocardial infarction |
| gptkbp:drugClass |
antidepressant
|
| gptkbp:eliminationHalfLife |
18–44 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pamelor
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision weight gain drowsiness dry mouth |
| gptkbp:synonym |
nortriptyline hydrochloride
|
| gptkbp:usedFor |
gptkb:depression
|
| gptkbp:bfsParent |
gptkb:Nortriptyline
gptkb:nortriptyline |
| gptkbp:bfsLayer |
7
|